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INTRODUCTION
1INTRODUCTION
In  general,  pregnancy  in  women is  considered  unique,  physiologically  normal 
episode in  women’s life.  However  preexisting morbidity  of  the mother  or  fetus can 
complicate pregnancy and as well as those arising during pregnancy and intrapartum 
make it a high risk one. “A pregnancy is defined as high risk, when the probability of an 
adverse outcome for  the mother or child is  increased over the base line risk of that 
outcome among the general population by the presence of one or more ascertainable risk 
factors”.2a
  “One such pre-existing maternal morbidity that makes a pregnancy high risk is 
obesity”.The magnitude of the obesity prevalence has been increasing in developed and 
developing nations, though in varying degrees. Also coming with the increase in obesity 
prevalence, inevitably, are the morbidities obesity promotes, including cardiovascular 
disease, diabetes, hypertension, stroke etc.  It becomes a major issue when it affects the 
women of reproductive age group, as obesity makes a pregnancy high risk, by the 
increased incidence of gestational diabetes, preeclampsia, gestational hypertension, 
labour induction, increased cesarean rates, anesthetic complications, postoperative 
morbidity, prolonged hospital stay etc..  
They are at increased risk of delivering large babies and NICU admission.
2Although routine weighing of pregnant women is being carried out in most of the 
antenatal clinics, not much of importance is given to the weight of the women as such. 
In  fact  prenatal  counseling  plays  a  vital  role  in  identifying  women who are  obese. 
Advice  on  weight  reduction before  embarking on pregnancy  will  go  a  long way in 
reducing the morbidity due to obesity in pregnancy.     
REVIEW OF LITERATURE
3REVIEW OF LITERATURE
WORLD WIDE PREVALENCE
For a number of years, obesity has been termed epidemic, strictly defined, the 
word  epidemic  implies  a  temporary  wide  spread  outbreak  of  greatly  increased 
frequency. Therefore obesity more currently is endemic, a condition that is habitually 
present.  Its  prevalence  is  increasing  world  wide  in  both  developed  and  developing 
countries.3a
In USA, from 1960- 1991 NHANES59 documented an alarming increase among 
the adults over the past  decades.  More than 127 million American adults were over 
weight, 60 million were obese and 9 million were severely obese. Among the women in 
1999 through 2000, 62% were overweight, 34% were obese, 6% were severely obese7.
The  incidence  of  obesity  in  pregnancy has  increased  in  concordance  with the 
prevalence  in  the  general  US  population.  The  reported  incidence  of  obesity  during 
pregnancy varies between 6% and 28% depending on the obesity definition, year and 
characteristics of the study population2,13,26,35,39,64,106.
4Further more, Lu et al26,106 examined the longitudinal trend of maternal obesity spanning 
from 1980-1999. They demonstrated that the incidence of obesity at the first prenatal 
visit increased from 7.3% to 24.4% in this 20 years time period.
Increasing prevalence of obesity during 20 years in pregnant women classified at the 
time of their first prenatal visit at the University of Alabama at Birmingham. (From Lu 
and Colleagues, 2001 with permission).
In a study by Glady36 et al, the largest proportion of obese was among American 
Africans 22% followed by Latins 14%, Whites 8% and the Asians 4%.
5In India a study conducted by Mohan et al68 at Chennai in 2001 the prevalence in 
age group more than 20 years was 22.5% males and 31.8% in females.
The various studies conducted in India are shown below:  
Prevalence of Obesity in India
Author City Centre Year Age (yr) Prevalence of 
Obesity(%)
Male Female
Dhurandhar & 
Kulkarni21
Bombay 1992 31-50 10.7-53.1 -
Gopinath et 
al38
Delhi 1994 25-64 21.3 33.4
Zargar et al107 Kashmir 2000 >40 7.0 23.7
Gopalan37 Nutrition 
foundation of 
India
1998 - 32.2
16.2
7.0
50
30.3
27.8
District 
Nutrition 
Profiles
 Survey54
Food and
Nutrition
Board
1998
- 1.0
0.3
0.4
4.0
0.7
0.7
National 
family health 
survey39
1998-1999 15-49 - 2.3
Mohan et al68 Chennai urban 
population 
study
2001 >20 22.8
21.5
31.8
36.5
Deshmukh et 
al21
Rural wardha 2006 >18 5.1
7.6
5.2
8.7
6Definition of Obesity
“Obesity  may be defined as  an abnormal  growth of  the adipose tissue due to 
enlargement of fat cell or increase in fat cell number or both43”. A number of systems 
have been used to define and classify obesity.1a
Assessment of Obesity
Although obesity can be easily identified at first sight, a precise assessment 
requires measurement and reference standards. Various methods49 to assess the obesity 
are as follows.
 Body Weight: 
Body weight  though not  an  accurate  measure  of  examining  fat,  is  a 
widely used index. The various indices used are:
1. Body mass index - BMI (Quetelet’s Index)
Weight (kg)
Height (m2)
2. Ponderal Index
Height (cms)
Cube root of body weight (kg)
3. Broca’s Index
Height (cm) -100
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4. Lorentz’s Formula
Height (cm) -100 – Height (cm) -150
            2 (Women) or 4 (men)
OTHER METHODS
Skin fold thickness50
Waist circumference and Waist: hip ratio99
USE OFBODY MASS INDEX (BMI) TO CLASSIFY OBESITY
BMI is a simple index of weight for height that is commonly used to identify 
underweight, overweight and obesity in adults.
“It is defined as weight in kgs divided by the square of the height in meters (kg/
m2)”1a.
The classification is as follows according to WHO and National Heart Lung and 
Blood Institute (1998)74.
CATEGORY      BMI
Under Weight <18.5 (kg/m2)
Normal Weight 18.5 – 24.99 (kg/m2)
Over Weight 25-29.99 (kg/m2)
Obese >30 (kg/m2)
8
It is believed to be a superior measure of adiposity than weight for height, but it 
too has limitations, that it does not incorporate a direct measure of body fat composition 
and distribution.
According to Freedman and Colleagues 200233 obesity is further classified as:
       CATEGORY       BMI
Class I (Moderate obesity) 30-34.9 (kg/m2)
Class II (Severe obesity) 35-39.9 (kg/m2)
Class III (Very severe obesity) >40 (kg/m2)
EPIDEMIOLOGICAL FACTORS
The etiology of obesity is complex and is one of multiple causation. 
Age:
Obesity can occur at any age but generally increase with age. 
Childhood obesity:
Infants with excessive weight gain have an increased incidence of obesity in later 
life. One third of obese adults have been so since childhood43.
Sex: 
Women generally have higher rate of obesity than men, although men have higher 
rate of overweight31.
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Pregnancy and Parity:
It has been claimed that women’s BMI increases with successive pregnancy. The 
evidence  suggested  that  this  increase  is  likely  to  be  about  1kg  /  pregnancy.  Hence 
multiparous women are obese when compared to nulliparous women74.
Genetic Factors:
There is a genetic component in the etiology of obesity28.
Physical Inactivity:
Sedentary  life  style  particularly  sedentary  occupation  and  inactive  recreation 
promote it. Physical inactivity may cause obesity which in turn restricts activity. This is 
a vicious cycle13,28,99.
Socio Economic Status:
Inverse relationship between socio economic status and obesity exist1a.
Eating Habits:
Eating in between meals, preference in sweets, refined foods and fats composition 
of the diet, periodicity with which it is eaten and the energy derived from it are all 
relevant to the etiology of obesity76.
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Psychosocial Factors:
Psychosocial factors are deeply involved in the etiology of obesity. Overeating 
may be a symptom of depression, anxiety, frustration1a.
Familial Tendency:
Obesity frequently runs in families1a.
Endocrine Factors:
These factors may be involved in occasional cases.
Eg. Cushing’s syndrome, growth hormone deficiency, hypothyroidism1a.
Alcohol:
The relationship between alcohol and adiposity is positive for men and negative 
for women100.
Education:
In affluent countries, inverse relationship between education and prevalence of 
obesity is seen100.
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Smoking:
Use of tobacco is reported to lower body weight1a
Ethnicity:
Ethnic groups in many industrialized countries appear to be especially  susceptible 
to  the  development  of  obesity  and  its  complications.  This  may  be  due  to  genetic 
predisposition74.
Drugs:
Use of certain drugs e.g. Corticosteroids, Contraceptives, Insulin, 
Beta blockers can promote weight gain74.
HAZARDS OF OBESITY
Metabolic Syndrome:
Obesity interacts with inherited factors and leads to the onset of insulin resistance. 
This metabolic abnormality in turn is responsible for altered glucose metabolism and a 
predisposition to type 2 diabetes and cardio vascular diseases and accelerate its course. 
The most important are type 2 diabetes, dyslipidemia and hypertension1,74. Prevalence is 
increased with age. According to NHANES III, prevalence was about 6% in those with 
20years of age, 14% in those with 30-39 years of age, 20% in those with 40-49 years of 
age and >30% for women over 50years of age32.
“20% in reproductive age group32.
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Other Complications:
Obesity cardiomyopathy 
Sleep apnea
Ischemic stroke
Gallbladder disease
Sub fertility
Carcinoma endometrium 
Deep Vein thrombosis
Poor wound healing
OBESITY IN PREGNANCY:
Definition:
In the past obesity in pregnancy was defined using various approaches.
In an effort to provide guidance on this issue in 1990 the Institute of Medicine 
(IOM94) recommended that, the BMI be used to define maternal weight groups. In 1993 
the ACOG released its BMI classification of maternal weight and optimal weight gain 
during pregnancy. As a result BMI now serves as a standardized means of evaluating the 
prevalence and outcomes of obesity during pregnancy6.
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Diagnosis:
For  practical  purposes,  it  is  useful  to  keep in  AN clinic,  acceptable  statistical 
tables which indicates the BMI for various heights and weights. One such calculated 
BMI values available in graphic form is shown here3a
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EFFECT OF OBESITY ON PREGNANCY 
ANTEPARTUM COMPLICATIONS
Sub fertility:
When considering the impact of obesity on pregnancy it is first important to note 
that obesity can be a barrier to reproduction. Several studies have reported an association 
between BMI and infertility40,41,83, which in the obese infertile women is mainly due to 
increased insulin resistance and related to amenorrhea and ovulatory dysfunction44. In 
their review, Neill and Nelson – Piercy 200173 linked impaired fecundity in women with 
BMI >30kg/m2.
In  addition obesity  has been associated with an increased risk of  spontaneous 
abortion in patients who receive infertility treatment10,29,95.  However obesity does not 
appear to be a risk factor for abortion in spontaneously conceived pregnancy71.
Pre-Pregnancy Medical Disorders:
Due to their strong association with obesity in the general population essential 
hypertension and diabetes mellitus are the two most common medical complications of 
obese gravida3.  Other  obesity  associated morbidities  such as Coronary heart  disease, 
stroke and cancer have a low prevalence in the reproductive age group71.
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Obstructive sleep apnea is a rare but serious obesity related morbidity. Data on 
this  complication  during  pregnancy  though  limited  suggested  that  obstructive  sleep 
apnea may be precipitated or exacerbated during pregnancy and may be associated with 
hypertensive disorders during pregnancy and impaired fetal growth58,61.
Pregnancy Specific Complications:
Gestational Diabetes:
Maternal  obesity  is  associated  with  an  increased  risk  of  gestational  diabetes. 
Incidence  varies  from  7%  to  17%.  This  increased  risk  is  primarily  related  to  an 
exaggerated  increase  in  insulin  resistance  in  the  obese  state14.  An  estimate  of  the 
incidence of gestational diabetes in the pregnancies of obese gravidas can be derived 
from the data of Gross et al42 and Ehrenberg et al26. who each reported a 6.5% and 8.0% 
incidence  of  gestational  diabetes,  respectively  in  obese  gravidas  who  were  from  a 
geographically similar U.S. urban population. In addition, the magnitude of this risk is 
positively  correlated  with  increase  in  maternal  weight26,87.  The  glucose  intolerance 
associated with gestational diabetes generally resolves after pregnancy. However women 
who are obese during pregnancy and develop gestational diabetes have been shown to 
have a 2-fold increased prevalence of subsequent type 2 diabetes as compared to lean 
women77.  Therefore maternal obesity is a significant long term risk factor for type 2 
diabetes67. 
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OBESITY-RELATED PREGNANCY COMPLICATIONS
Author, 
Year
Medical 
Complications
Antepartum 
Complications
Intrapartum 
Complications
Postpartum 
Complications
Perinatal 
Complications
Edwards et 
al 197824
Hypertensive disorders 
of pregnancy, Mild Pre-
eclampsia, Gestational 
diabetes, inadequate 
pregnancy weight gain 
(<12lb)
Wound 
episiotomy 
infection
Birth weight >4kg
Gross et al 
198042
Hypertension 
diabetes mellitus
Gestational diabetes, 
Multiple gestation, 
inadequate weight gain
Labor induction 
Fourth degree 
laceration 
Birth weight >4kg 
LGA
Calandra et 
al.198113
Labor Induction Fever Birth Weight >4kg
Garbaciak et 
al 198535
Hypertension 
diabetes mellitus 
Thyroid disease 
syphilis
Pre-eclampsia, Urinary 
tract infection
Primary cesarean 
Meconium Late 
decelerations
Abrams et 
al, 19883
Hypertension 
diabetes mellitus
Pregnancy induced 
hypertension, Gestational 
diabetes
Primary cesarean
Naeye, 
199070
Hypertension 
diabetes mellitus 
Preterm birth < 30wks, 
Twins
Congenital 
anomaly Perinatal 
mortality
Perlow et al, 
199279
Hypertension 
diabetes mellitus
Gestational diabetes Cesarean, 
primary cesarean
Birth Weight 
<2.5kg
Birth weight >4kg
SGA
NICU admission
Johnson et 
al,199252
Postdates Labor induction, 
cesarean, 
Meconium
Birth Weight >4kg
Cnattingius 
et al 199819
Diabetes mellitus Gestational diabetes, 
Pre-eclampsia, Preterm 
birth <32wks
Late fetal death 
Early neonatal 
death.
Bianco et 
al,199811
Hypertension 
Diabetes Mellitus 
Asthma
Pre-eclampsia, 
Gestational diabetes, 
Abruption
Meconium, 
Labor arrest 
,Cesarean
Endometritis LGA
Baeten et al 
20019
Gestational diabetes, 
Pre-eclampsia, Preterm 
Birth <32wks
Cesarean Birth weight >4kg 
Infant death.
Sebire et al, 
200187
Gestational diabetes, 
Pre-eclampsia, Urinary 
tract infection
Labor induction, 
Emergency 
Cesarean
Hemorrhage 
Genital tract 
infection 
Wound 
infection
LGA Fetal Death 
Delayed lactation
Lu et al, 
200164 
Ehrenberg et 
al, 200226
Diabetes Mellitus
Gestational diabetes, 
Pre-eclampsia, Postterm 
gestation
Cesarean
LGA
Birth weight >4kg
Birth weight 
>4.5kg
Jensen et al, 
200351
Postterm gestation, 
Pre-eclampsia
Labour 
Induction, 
Cesarean
LGA, Birth Weight 
>4kg.
Clinical Obstetrics and Gynecology (Brown Journal, Vol. 47; No-4:900-901, 2004)
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Hypertensive Disorders:
The association between obesity and hypertensive disorders during pregnancy has 
been  a  consistent  finding  in  the  obstetrical  literature35,51,65,87.  Specifically,  maternal 
weight and BMI have been validated as independent risk factors for pre-eclampsia90,91. 
Sibai  et  al90,91 reported a  significant  difference in the incidence of  pre-eclampsia  for 
women with an early second trimester BMI <20 kg/m2 (4.3%) as compared to when the 
BMI was > 34 kg/m2 (12.6% , P < 0.0001). The mechanism by which obesity imparts an 
increased resistance and subclinical inflammation and endothelial dysfunction are also 
responsible for the increased incidence of pre-eclampsia in obese gravidas12,75,104.
Preterm Birth
Conflicting data exist regarding the relationship between maternal obesity and the 
risk for preterm birth. Naeye70, in an analysis of data from the Colloborative Perinatal 
Study undertaken from 1959 through 1966, reported an increasing incidence of preterm 
birth between 24 to 34 weeks gestation associated with increasing maternal pregravid 
body weight. The increased incidence of preterm birth was attributed to an increased 
prevalence  of  chorioamnionitis  and  twin  gestations  in  the  higher  maternal  weight 
groups.  In a more recent population based cohort  analysis of Washington state birth 
certificates, Baeten et al9 reported an increased risk for preterm birth  < 32 weeks  for 
women with a pre-pregnancy 
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BMI  > 30  kg/m2,  which  remained  significant  when  women  without  antenatal 
complications were analyzed separately  (Odd’s Ratio = 1.5).
In contrast, in a larger population-based cohort study from Sweden, Cnattingius et 
al19 reported an overall increased risk for preterm birth < 32 weeks in nulliparas with a 
BMI > 30 kg/m2 (or 1.6:95% CI 1.1-2.3), but this risk was no longer significant when 
women with hypertensive disease were excluded. Similarly, in a large population-based 
cohort  study from England,  Sebire et  al87 reported no association between BMI and 
preterm birth  < 32 weeks when analyses were adjusted for antepartum complications. 
These data suggest that the increased risk of preterm birth in obese gravidas is primarily 
associated  with  obesity  related  medical  and  antenatal  complications  and  not  some 
intrinsic predisposition to spontaneous preterm birth.
Prolonged Pregnancy:
There is a growing body of evidence to support the association between obesity 
and prolonged pregnancy. Although early reports by Calandra et al13 and Gross et al42 
failed to identify an association between maternal obesity and the incidence of post term 
(>42  weeks)  pregnancy,  Johnson  et  al52 subsequently  reported  an  independent 
association between increasing maternal prepregnancy weight and BMI and the risk for 
postterm pregnancy. More recently in 2 large cohort studies. Ehrenberg et al26 reported 
an increased risk for prolonged pregnancy among obese gravidas (Odd’s Ratio 1.5) as 
did Sebire et al87 (Odd’s Ratio1.72).
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Multifetal Gestation
An increased incidence of multifetal gestation has been reported among obese 
gravidas. (Gross et al42, Naeye70)
Urinary Tract Infection
In  a  pooled  analysis  of  3  studies,2,24,35 Abrams et  al2 reported  that  being  over 
weight prior to pregnancy was associated with a 42% increased risk for urinary tract 
infections. Its findings have been substantiated by Sebire et al87.
Others
There is no evidence to support an increased risk of abruptio placentae or placenta 
previa. (Wolfe HM, et al103 1994). But results of other studies  (Bainco et al11, 1998) are 
conflicting. 
Ultrasound in Obese Pregnant Mothers
Obesity can limit the prenatal diagnosis of congenital malformations. Wolfe et 
al103 studied  the  relationship  between  BMI  and  the  visualization  of  fetal  anatomy. 
Although obesity  poses  a  significant  challenge  to  the  obstetrical  sonographer  in  the 
diagnosis of fetal malformations, it does not seem to hinder sonographic estimations of 
fetal weight 31,105.
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Practical Difficulties:
1. Clinical diagnosis of pregnancy is sometimes difficult 
2. As pregnancy proceeds it is difficult to evaluate size of the uterus, weight of the 
fetus, to determine the presenting part, to detect fetal heart sound, presence or 
absence of hydramnios.
3. Maternal Blood Pressure is difficult to determine using standard cuff and may 
show artificially high blood pressure75.
4. Difficulty in sonographic visualization in women (Wolfe et al 1990).
5. Cephalo pelvic relationships are difficult to estimate in obese women but potential 
risk is always present, particularly as multiparity and increased lordosis caused by 
obesity are both predeterminants of spondylolisthesis.
6. Dyspnea due to exertion.
7. Placing of intravenous lines may be difficult.
8. Difficulty in monitoring maternal and fetal well being can occur. 
Intrapartum Complications
Labour Induction:
Understanding of the relationships between obesity and labour characteristics is 
evolving.  Obese  gravidas  were  known  to  have  an  increased  incidence  of  labour 
induction13,25,27,42. Estimates of the magnitude of this risk range 
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from a 1.7 fold to 2.2 fold increase which remains significant even after adjustment for 
associated antepartum complications51,52,87.
Dysfunctional Labour
Investigations on the labour characteristics of the obese gravidas are limited and 
conflicting. Gross et al42 found no difference in the major dysfunctional labour patterns 
between obese and non obese parturients. Ekblad et al30 also found no difference in the 
duration of the first and second stage of labour between obese parturients or those with 
excessive weight gain and controls. However Johnson et al52 reported a higher risk for 
labour  abnormalities  with  both increasing  prepregnancy  BMI and gestational  weight 
gain.
Cesarean Delivery:
The primary intrapartum complication of obesity is an increased risk for cesarean 
delivery. Both pre-pregnancy obesity20,55 and excessive maternal weight gain contribute 
to an increased cesarean risk. Importantly these associations appear to be independent of 
obesity  related  antenatal  complications,  short  maternal  stature,  higher  infant  birth 
weights, and gestational age at delivery53,55,105,106. The factors that contribute to obesity 
related increased cesarean risks are not clear. In a large population based cohort study of 
nulliparas conducted  in  Sweden,  Cnattingius  et  al19 demonstrated  that  cesarean  rates 
increased  consistently  with  decreasing  maternal  height  and  increasing  prepregnancy 
BMI. Subsequently, 
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Young et al106 reported that  among a large cohort of nulliparous women the obesity 
related increase in cesarean was primarily mediated through an increase in cesarean for 
cephalopelvic  disproportion,  failure  to  progress,  which  was  independent  of  maternal 
height. As previously discussed, there is a lack of consistent evidence to support a higher 
incidence  of  specific  dysfunctional  labour  patterns  among  obese  parturients.  These 
preliminary data therefore suggest that obesity may lead to dystocia due to increased soft 
tissue deposition of the pelvis.
Intraoperative Complications
Cesarean  in  the  obese  gravida  is  more  often  performed  emergently  and  is 
associated  with  prolonged  incision  to  delivery  interval,  blood  loss  >1000ml,  longer 
operative times18,24,78,87 and difficulty in delivering the baby.
Skin Incision
Pfannenstiel incisions are believed to provide a more secure wound closure and 
less postoperative pain which can lead to early ambulation and improved respiratory 
function78,102. 
Anesthetic Complication
Increased subcutaneous fat increases the difficulty in placing regional anesthesia 
and increases the rate of placement failure and thus the need for general 
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anesthesia8. Ranta  et  al81 reported  that  obese  parturient  experience  more  technical 
problems  in  establishing  epidural  anaesthesia,  such  as  inadvertent  dural  puncture, 
multiple attempts at placement and senior anesthetist consultation, but experienced an 
equal  response  to  pain  treatment.  The  greater  incidence  of  medical  and  antenatal 
complications,  increased  risk  of  cesarean  section  and higher  incidence  of  anesthetic 
complications necessitates timely anesthetic evaluation in all obese parturient.
Others
Investigations  that  controlled  for  birth  weight,  the  incidence  of  intrapartum 
complications such as shoulder dystocia, malpresentation, hemorrhage, and 4th degree 
laceration did not appear to increase in obese gravida11,13,24,51. However because maternal 
obesity is a risk factor for fetal macrosomia, the clinician should still anticipate these 
complications. An increased incidence of intrapartum fetal heart rate abnormalities, cord 
accidents  and  meconium  stained  amniotic  fluid  has  been  associated  with  maternal 
obesity35,52.
Wound complications:  
Obese women have increased rates of wound infection and wound dehiscence. 
Myles  et  al69 found  that  obesity  was  an  independent  risk  factor  for  post  cesarean 
morbidity in women.
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Postpartum Complications:
Whether delivered vaginally or by cesarean the obese gravida is at higher risk of 
postpartum endomyometritis, laceration/episiotomy infection and wound 
infection11,24,78,87.  Several studies reported a lack of association between postpartum 
hemorrhage and maternal obesity.
Lactation dysfunction may be another postpartum complication of obesity. Study 
results are conflicting16,61,82,85.
The  cumulative  effect  of  obesity  related  complications  during  the  postpartum 
period is a resultant prolongation of hospitalization47,78.
Prolonged hospitalization for the obese gravida ultimately translates into increased 
health care costs34,47.
Perinatal Outcome
Birth weight:
Pre-pregnancy obesity and maternal weight gain both play an important role in 
determining infant birth weight. Also gestational diabetes is complicated by excessive 
numbers of  large for  gestational  age and macrosomic  infants.  As a  result  the  obese 
gravida is at increased risk of delivering a high birth weight infant13,24,26,42,52,64.
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Anomalies:
There has been an accumulation of evidence to support that maternal obesity is 
associated with an increased risk of congenital malformations. Watkins et al96 found that 
the offspring of obese women have 2-fold increased risk for neural tube defects.
Other  malformations  are  heart  defects,  ventral  wall  defects  and  orofacial 
defects80,89,97.
Morbidity and Mortality:
Two important and interrelated co-factors that contribute to excessive perinatal 
morbidity and mortality are chronic hypertension and diabetes mellitus, both of which 
are associated with obesity. Chronic hypertension is a well known cause of fetal growth 
restriction.  Pre-gestational  diabetes  increases  the  rate  of  birth  defects.  The  obesity 
related preterm birth accounted for nearly half of the mortality.
More recent studies also suggested that obesity is associated with an increased 
risk of still birth – 1.4 to 2.6 fold increased risk for fetal death9,55,87.
A final outcome to consider is the potential impact of maternal obesity and weight 
gain on subsequent childhood obesity57,92,98.
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Contraception:
Oral contraceptive pill failure is more likely in overweight women. According to 
Holt  and Colleagues  200246 women in  the highest  weight  quartile  had  sixteen-  fold 
increased risk of pregnancy. Women who used very low dose OCP had 4-5 fold increase 
in pregnancy rate43.
Long Term Consequences:
It is intuitive that excessive prepregnancy weight can be used to predict long term 
obesity  with  its  attendant  morbidity  and  mortality.  Rooney  and  Schauberger86 2002 
however, reported the excess weight gain during pregnancy but not pre-pregnancy - is a 
predictor of long term obesity.
AIM OF THE STUDY
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AIM OF THE STUDY
The aim of this study is to evaluate the effect of obesity on the maternal and 
perinatal outcome in pregnancies complicated by obesity.
MATERIALS AND METHODS
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MATERIALS AND METHODS
Study Design: Prospective Cohort Study
Period of Study: July 2005 – June 2006
Place of Study: Institute of Obstetrics and Gynecology, Egmore, Chennai.
Case Selection
Among antenatal mothers attending antenatal outpatient department, mothers were 
chosen in their first trimester who had Body Mass Index >  30kg /m2 as study group and 
mothers with a Body Mass Index between 18.5 kg/m2  and 25kg/m2 as control group.
Inclusion Criteria
1. Pregnant women with first trimester BMI >30kg/m2.
2. Pregnant women with first trimester BMI between 18.5kg/m2 and 25kg/m2.
3. Irrespective of age, parity, socio-economic status.
Exclusion Criteria
1. Mothers not booked at First Trimester 
2. Miscarriage 
3. Anomalous baby
4. Women with BMI between 25.1kg/m2 and 29.9kg/m2.
5. Women with BMI <18.5kg/m2.
6. Women who could not be followed until delivery
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Method of Study
Pregnant  mothers  were  selected  according  to  the  criteria  and  in  all  women 
detailed  history  followed  by  complete  general  and  physical  examination  was  done. 
Relevant  hematological,  biochemical  investigations,  USG  were  done.  They  were 
followed up to delivery and postpartum until discharge and outcome studied.
History
In  these  women  relevant  history  such  as  age,  parity,  socioeconomic  status, 
menstrual history, infertility, hypertension, diabetes, hypothyroidism, or other medical 
illnesses. History of previous pregnancy outcome was obtained in detail. Family history 
of obesity, hypertension and diabetes, were enquired.
Physical Examination
Detailed  physical  examination  with  regards  to  weight  gain,  pulse,  BP  were 
recorded. They were examined for anaemia, pedal edema and systemic examination of 
Cardiovascular System, Respiratory System and Central Nervous System was done.
LAB INVESTIGATION
Relevant investigations were done in each case.
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Follow-up of Cases
With above information, the antenatal mothers were followed up during antenatal 
period, delivery and postpartum until discharge. They were looked for 
the development of : 
Gestational diabetes mellitus 
Pre-eclampsia
Gestational hypertension
Malpresentation 
Multiple pregnancy
Abruptio placenta
Placenta previa
Labour induction and their indication
Mode of delivery (Vaginal / Cesarean delivery)
Shoulder dystocia
Instrumental delivery
Postpartum hemorrhage
Deep vein thrombosis 
Postoperative wound infection
Postoperative wound dehiscence
Duration of hospital stay
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Neonates
• Gestational age at birth
• Birth weight
• Apgar at 5 minutes 
• Admission in NICU and indications for admission were analysed 
Statistical Analysis:
Differences between groups were evaluated using chi- square and student t test 
and statistical significance was deemed at a p value of < 0.05. Odd’s ratio was calculated 
expressing the relationship between obesity group and specific maternal outcomes.
DATA ANALYSIS
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DATA  ANALYSIS
One Hundred and Five pregnant women with BMI > 30kg/m2 and Two Hundred 
and  Ten  pregnant  women  with  BMI  18.5kg/m2 to  25kg/m2  were  selected  and  were 
followed prospectively. Six Obese women were excluded from the study, as four women 
had miscarriage, one lost for follow-up and one had anomalous baby. Nine women with 
normal BMI were excluded from the study, as five women had miscarriages, three lost 
for follow-up and one had anomalous baby. The remaining ninety nine obese women 
and two hundred and one women with normal BMI were studied.
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MATERNAL AGE DISTRIBUTION:
AGE (YEARS)
Control Obese
No Percentage No Percentage
<20 13 6.47% 1 1.01%
20-24 114 56.72% 29 29.29%
25-29 56 27.86% 41 41.41%
> 30 18 8.96% 28 28.28%
P <0.05 (Significant)
The majority of obese women (41.41%) were between 25-29yrs where as majority 
of control women (56.72%) were between 20-24yrs. Proportion of women in the age 
group  >30yrs were 28.28% in obese group and only 8.96% in control group. This 
difference in age group distribution was statistically significant. 
AGE IN YEARS
Group Total Mean 
Years
Standard 
Deviation
Student t-test
Control 201 24.14 3.424
Obese 99 27.01 4.525
T=6.12
P=0.001
The mean age in obese group was 27.01years where as in control group it was 
24.14 years (P= 0.001). Obese women tend to be older. 
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MATERNAL WEIGHT 
Group Total Mean (kg) Standard 
Deviation
Student –t 
Test
Wt at 
Booking
Control 
Obese
201
99
51.25
76.73
4.682
9.065
T=32.1
P=0.001
BMI at Control 201 21.70.35 1.70879 T=43.3
Booking Obese 99 32.7313 2.66237 P=0.001
Wt at 
delivery
Control 
Obese
201
99
61.33
83.94
5.602
9.056
T=26.6
P=0.001
The mean weight at booking in obese women was 76.73kg and in control women, 
it was 51.25kg. The mean BMI at booking in obese women was 32.7313kg/m2 and in 
control women it was 21.7035 kg/m2. The mean weight at term in obese women was 
83.94kg and in control women it was 61.33kg.
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SOCIOECONOMIC STATUS
Socioeconomic Class
Control Obese
No Percentage No Percentage
I - - - -
II 2 1% 1 1.01%
III 12 5.97% 12 12.12%
IV 63 31.34% 37 37.37%
V 124 61.69% 49 49.49%
X2=5.61, P>0.05 Not significant
Most of the women in obese and control groups belonged to Class V. 
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CATEGORISATION OF OBESE WOMEN
BMI kg/m2 Category Numbers Percentage
30-34.9 Moderate Obesity 82 82.82%
35-39.9 Severe Obesity 12 12.12%
> 40 Very Severe 
Obesity
5 5.56%
In the study group 82.82% were moderately obese, 12% were severely obese and 
only 5.56% were very severely obese.
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PARITY
Parity Control Obese
No Percentage No Percentage
Nulliparous 92 45.77% 36 36.36%
Para I 101 50.25% 54 54.54%
Para II 8 3.98% 9 9.09%
X2=11.02, P=0.02 (Significant)
Among obese women 36.36% were nulliparous and 63.63% were parous women, 
where as in control group 45.77% were nulliparous and 54.23% were parous women. 
MEAN BMI IN OBESE POPULATION IN RELATION TO PARITY
Parity Mean BMI (kg/m2)
Nulliparous 32.09
Para I 32.87
Para II 34.38
As parity increased the mean BMI increased among obese women.
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MENSTRUAL PATTERN 
Menstrual 
Pattern
Control Obese
No Percentage No Percentage
Regular 196 97.51% 81 81.82%
Irregular 5 2.49% 18 18.18%
X2=22.7    p=0.001 (Significant)
18.18% of obese women had irregular menstrual pattern where as only 2.49% of 
control women had irregular menstrual pattern. 
INFERTILITY
Infertility
Control(201) Obese(99)
No Percentage No Percentage
Yes 5 2.49% 20 20.20%
No 196 97.51% 79 79.80%
X2=27.3, P=0.001 (Significant)
In obese women 20.20% had infertility where as in control women it was 2.49%. 
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PREPREGNANCY MEDICAL DISORDERS
Medical Disorders Control Obese
No Percentage No Percentage
Diabetes 0 - 2 2.02%
Hypertension 1 0.5% 2 2.02%
Hypothyroidism 4 1.99% 10 10.1%
Asthma 1 0.5% 0 -
Epilepsy 2 1% 1 1.01%
Heart disease 1 0.5% 0 -
Two were diabetic in obese group, where as none were so in control group. Two 
Obese women were hypertensive, where as none were so in control group. These were 
not statistically significant as were other disorders namely asthma, epilepsy and heart 
disease. 10 obese women (10.10%) were hypothyroid, but in control only four were so 
(1.99%). This difference was statistically significant (P=0.001).
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PREGNANCY RELATED MEDICAL DISORDERS
Complications Control Obese
No Percentage No Percentage
Test of 
Significance
Odds 
Ratio
Gestational 
Diabetes 
Mellitus
4 1.99% 10 10.1% P <0.05 5.53
Preeclampsia 12 5.97% 13 13.13% P <0.05 2.38
Gestational 
Hypertension
6 2.99% 10 10.10% P <0.05 3.65
The incidence of gestational diabetes was 10.1% and 1.99% respectively in obese 
and control group. The incidence of pre-eclampsia was 13.13% and 5.97% in obese and 
control group respectively. The incidence of gestational hypertension was 10.1%  and 
2.99% in obese and control group respectively. The results were statistically significant. 
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OTHER OBSTETRIC COMPLICATIONS
Complications Control Obese
No Percentage No Percentage
Multiple pregnancy 2 1% 1 1.01%
Abruptio placenta 1 0.5% 1 1.01%
Placenta previa 1 0.5% 1     1.01%
Malpresentation
        Breech
        Face
8 3.98% 5
1
5%
1.01%
P >0.05 (Not – Significant)
Obstetric  complications  like  multiple  pregnancy,  placenta  previa,  abruptio 
placenta  and  malpresentation  existed  in  both  groups,  but  the  difference  was  not 
statistically significant.
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INDUCTION OF LABOUR
Induction Control Obese
No Percentage No Percentage
Yes 10 4.98% 12 12.1%
No 19
1
95.02% 87 87.9%
X2 = 3.84, P=0.05, Odd’s Ratio: 2.55
The labour  induction rates  were 12.1% and 4.9% in  obese  and control  group 
respectively. The rates were higher in obese group and the difference was statistically 
significant. Obese women had 2.5 times increased risk of being induced than control 
women.
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INDICATIONS FOR LABOUR INDUCTION
Indication Control Obese
No Percentage No    Percentage
Gestational 
hypertension
- 3 25%
Pre-eclampsia 3 30% 4 33.33%
Pre-eclampsia with 
IUGR
- 1 8.33%
Post datism 4 40% 3 25%
PROM 1 10% -
PPROM 1 10% 1 8.33%
Oligohydramnios 1 10% 1
In obese group the majority of induction of labour was done for  hypertensive 
disorders of pregnancy (66.66%). Post datism was the major reason for induction in 
control group (40%).
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MODE OF DELIVERY
MODE OF 
DELIVERY
CONTROL OBESE
No Percentage No Percentage
Labour natural 133 66.17% 41 41.41%
Primary cesarean 
delivery
28 13.93% 25 25.25%
Repeat  cesarean 
delivery
33 16.42% 31 31.31%
Forceps delivery 4 1.99% 1 1.01%
Assisted breech 
delivery
1 0.5% - -
VBAC 2 1% 1 1.01%
X2=19.51, P=0.001, Significant
The labour natural was lower in obese group (41.41%) when compared to control 
group  (66.17%).  The  primary  cesarean  delivery  rates  were  higher  in  obese  group 
(25.25%), when compared to control group (13.93%). The instrumental delivery rates 
and VBAC rates were 1.01% and 1% in obese group and 1.99% and 1% in control group 
respectively and were almost equal in both groups. 
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CESAREAN DELIVERY RATES 
Mode of 
Delivery
Control Obese
MODERATE SEVERE VERY 
SEVERE
TOTAL
Vaginal 
Delivery
140 
(69.65%)
38
(46.34%)
4 
(33.33%)
1 
(20%)
43 
(43.43%)
Cesarean 
Delivery
61
(30.35%)
44
(53.66%)
8 
(66.67%)
4 
(80%)
56 
(56.57%)
X2=19.16, P=0.001, Odd’s Ratio: 2.98
The Cesarean delivery rates were higher in obese group (56.57%) than control 
group (30.35%). Obese women had 2.8 fold increased risk of cesarean delivery than non 
obese women. The rates increased with severity of obesity.
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PRIMARY CESAREAN DELIVERY
 Control Obese
No Percentage No Percentage
Odd’s Ratio
Emergency 24 17.64% 21 31.34% 2.13
Elective 4 2.94% 4 5.97% 2.06
Total 28 20.58% 25 37.31% 2.29
The primary Cesarean delivery rates were 37.31% in obese group and 20.58% in 
control group. Obese women had 2.29 times increased risk for cesarean delivery than 
control group. Obese women had higher risk of emergency cesarean delivery (31.34% 
Odd’s ratio: 2.13) than control  group (17.64%). Similarly obese women had increased 
risk  of  elective  cesarean  delivery  (5.97%,  Odd’s  Ratio:  2.09)  than  control  group 
(2.94%).
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INDICATIONS FOR PRIMARY EMERGENCY CESAREAN DELIVERY
Indications Control Obese
No Percentage No Percentage
Cephalo Pelvic 
Disproportion 
5 20.83% 5 23.8%
Failure to progress 3 12.5% 2 9.52%
Fetal Distress 6 25% 6 28.57%
Failed Induction 4 16.67% 4 19.04%
Malpresentation 4 16.67% 2 9.52%
Imminent eclampsia - - 1 4.76%
Placenta previa - - 1 4.76%
Failed forceps 1 4.17% - -
Deep transverse arrest 1 4.17% - -
The major reasons for emergency cesarean delivery were fetal distress, cephalo pelvic 
disproportion and failed induction in both groups.
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MODE OF DELIVERY ACCORDING TO PARITY
CONTROL OBESE
Mode of 
Delivery
Nulliparous
(92)
Previous 
Normal 
Delivery 
(74)
Previous 
Cesarean 
Delivery 
(35)
Nulliparous
       (36)
Previous 
Normal 
Delivery 
(31)
Previous 
Cesarean 
Delivery
(32)
Vaginal 
Delivery
70
(76.09%)
68
(91.89%)
2
(5.71%)
20
(55.26%)
22
(70.97%)
1
(3.12%)
Cesarean 
Delivery
22
(23.91%)
6
(8.11%)
33
(94.29%)
16
(44.44%)
9
(29.03%)
31
(96.88%)
In nulliparous women, caesarean delivery was higher in obese group  (44.44%) 
when  compared  to  control  group  (23.91%)  (P=0.01  significant,  Odd’s  Ratio:  2.55). 
Obese nulliparous women had 2.5 fold increased risk for cesarean delivery. Similarly in 
parous women with previous normal delivery, cesarean delivery was higher in obese 
group (29.03%) than control group (8.11%) (P=0.01 significant). The repeat caesarean 
rate was almost similar in both groups.
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INTRAPARTUM COMPLICATIONS
Complications Control Obese
Shoulder dystocia - -
Complete perineal tear - -
Hemorrhage 1 1
No shoulder dystocia or complete perineal tear was seen in either group. There 
was one case of atonic hemorrhage in each group.
POSTPARTUM COMPLICATIONS
Complications Control Obese
Odd’s Ratio
No Percentage No Percentage
Wound Infection 6 (9.84%) 13 (23.21%) 2.77
Wound 
Dehiscence 1 (1.67%) 5 (8.93%) 3.12
Deep Vein 
Thrombosis
- - -
P<0.05 Significant.
Wound infection and dehiscence rates were higher in obese group 
(23.21% and 8.93%) than control group (9.84% and 1.67%) respectively. Obese group 
had  2.47  fold  and  3.12  fold  increased  risk  for  wound  infection  and  dehiscence 
respectively than control group. Postpartum deep vein thrombosis was not seen in either 
group.
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GESTATIONAL AGE AT DELIVERY
Gestational Age 
(Weeks)
Control Obese
No Percentage No Percentage
>37 196 97.5% 95 95.96%
35-37.6 3 1.49% 2 2.22%
32-34.6 2 1% 2 2.22%
X2=0.65            P=0.72            Not Significant
95.96% of  obese  women and 97.5% of  control  women delivered at  term and 
4.22% of obese women and 2.49% of control group delivered preterm. The difference 
was not statistically significant.
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BIRTH WEIGHT OF THE NEONATE
Birth Weight (kg)
Control Obese
No Percentage No Percentage
1.5-1.99 1 0.49% 2 2%
2.0-2.49 8 3.94% 2 2%
2.5-2.99 98 48.28% 27 27%
3.0-3.49 78 38.42% 44 44%
3.5-3.99 18 8.87% 22 22%
>4 - - 3 3%
TOTAL 203 100
P<0.05 Significant
Majority of the neonates of obese women (44%) were between 
3kg-3.49kg and of control women (48.28%) were between 2.5kg – 2.99kg.  22% babies 
of obese women were between 3.5kg-3.99kg when compared to 8.87% babies of control 
women. 3 babies were >4kg in obese women but none in control group.
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MEAN BIRTH WEIGHT OF THE NEONATE
Numbers Mean (kg) Standard 
Deviation 
Student –t Test
Control 203 2.92 0.323
Obese 100 3.16 0.442
T=4.80
P=0.001
The mean birth weight of the neonate was 3.16kg in obese group and 2.92kg in 
Control group.
APGAR AT 5 MINUTES
Apgar at 
5min
Control Obese
No Percentage No Percentage
<7 3 1.48% 3 3%
> 7 200 98.52% 97 97%
Total 203 100
The difference of Apgar at 5minutes between obese and control group was not 
statistically significant (P>0.05).
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NICU ADMISSIONS AND THEIR INDICATIONS
Indication
Control Obese
No Percentage No Percentage
Meconium Aspiration 5 29.4% 3 14.28%
Asphyxia 1 5.8% - -
Transient Tachypnia of 
New born
2 11.76% - -
Infant of Diabetic 
mother with RDS
- - 2 9.5%
Infant of Diabetic 
Mother
4 23.53% 8 38.09%
Preterm 4 23.53% 4 19.05%
IUGR 1 5.8% 1 4.76%
Abnormality - - 2 9.52%
Macrosomia - - 2 9.52%
Total 17 8.37% 21 21%
21% of babies born to obese women and 8.37% babies of control women were 
admitted in NICU. (P <0.05). The major reason for admission of babies of obese women 
was for  the care  of  infants  of  diabetic  mother  and in  control  group the reason was 
meconium aspiration.
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HOSPITAL STAY
Hospital 
Stay
Control Obese
No Percentage No Percentage
P value
Vaginal 
Delivery
2 days 125 89.29% 32 74.42%
> 2days 15 10.71% 11 25.58%
<0.05
Cesarean 
Delivery
7 days 54 88.52% 41 73.21%
>7 days 7 11.48% 15 26.79%
<0.05
Among vaginal delivery group 25.58% of obese women and 10.71% of control 
women required prolonged hospital stay (>2days) and in cesarean delivery group 
26.79% of obese women and 11.48% of control women required prolonged hospital stay 
(>7days).
DISCUSSION
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DISCUSSION
In our study, women in the obese group were slightly older when compared to 
women with normal BMI. The mean maternal age in obese group was 27.01yrs. Obese 
women were less likely to be nulliparous. Mean BMI in obese group increased with 
parity.  This  is  in  accordance  with  the  results  of  Ehrenberg  HM  et  al  200226that, 
increasing age and parity are risk factors for obesity.
We  observed  that  obese  women  had  increased  menstrual  abnormalities  and 
infertility when compared to women with normal BMI. This is consistent with studies 
done by Hartz AZ et al  197944 and Neil and Nelson 200173 that,  obese women have 
menstrual abnormalities related to ovulatory dysfunction and insulin resistance leading 
to infertility.
Previous studies show that obese women have increased incidence of preexisting 
diabetes  and  chronic  hypertension,  complicating  pregnancy.  (Perlow  et  al  199279, 
Garbaciak 198535). But our study failed to show such association, which may be due to 
the small size of the sample. Obese women had increased incidence of hypothyroidism 
(10%), in accordance with Garbaciak et al 198535.
In obese group, we found increased risk of pre-eclampsia (13.13%). The 
frequency was almost 2.3 times as high for obese group as it was for group with normal 
BMI. 
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Obese women were observed to have an increased incidence of gestational 
hypertension (10.1%) when compared with control group (2.99%). The risk of 
gestational hypertension among obese women was increased almost 3.6 fold.            
          In our population, obese group exhibited a higher risk of developing 
gestational diabetes (10.1 %,) when compared to normal BMI group (1.99%). There was 
5.53 fold risk increase for gestational diabetes among obese women.     
           Our study results were consistent with several studies: 
Gestational diabetes
Our study
Gross et al (1980)42
Ehren Berg et al 200226
Glady et al 200536
Glady et al 200536
10.1%
6.5%
8%
8%
14% (Asians)
Pre-eclampsia Our sudy 13.13%
Sibai et al 199590
Heather E. Robinson et 
al 2005.45
Glady et al 200536
Glady et al 200536 
12.6%
18.9% - 22.6%
16%
13% (Asian)
Gestational 
Hypertension
Our study
Joshua .L. Weiss et al 
200453
10.1%
10.2%
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In  our  study,  placental  abnormalities  such  as  placenta  previa  and  placental 
abruption occurred equally among obese women and normal weight women. Bainco et 
al11 showed an increased incidence of abruption, but results of Wolf HM  et al 199410 
including ours did not show association.
There was no significant  association with multiple pregnancy and BMI in our 
study, which occurred equally in obese group (1.0%) and control group (1%). This is 
consistent with study done by Marie. I Cedergren65.  But other studies have reported, 
increased incidence of multiple pregnancy. (Gross T. et al, 198042, Naeye RL, 199070)
We observed that  labour  induction was more common in obese group(12.1%) 
when  compared  to  control  group(4.9%),  which  is  in  accordance  with  other  studies,
(Ekblad U et al 199227). The risk of induction among the obese women was increased 
almost  2.5 fold.  Cedergren et  al,  200465 in his study had an incidence ranging from 
13.1% -18.3% according to the severity of obesity. In our study, the major reason for the 
induction was hypertensive disorders of pregnancy (66.6%) in obese group.
    In the obese group, our results supported a number of previous studies (Joshua-
L-Weiss  et  al  200153  and Marie  -I  -  Cedergren  200465 )  that  have  demonstrated  an 
increased risk for cesarean delivery in this group.      
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The cesarean delivery rates were 56.57% in obese group and 30.35% in control 
group. Obese women had 2.8 fold increased risk of cesarean delivery when compared to 
control group. The risk increased with the severity of obesity. The primary caesarean 
delivery rates were higher among obese group (25.5%) when compared to control group 
(13.93%). The caesarean delivery rates were higher among nulliparous obese group and 
even,  obese  women  with  previous  normal  delivery  had  higher  risk  for  caesarean 
delivery. Obese nulliparous women had 2.5 fold increased risk of cesarean delivery than 
lean  women.  We  also  found  that,  both  emergency  and  elective  primary  cesarean 
deliveries were increased in obese group. We found no difference in repeat cesarean 
delivery rates between two groups. 
Instrumental deliveries were surprisingly not increased in obese group, which is in 
contrast to other studies (Joshua. L. Weiss et al, 200153, Marie. I Cedergren 200465.The 
increased cesarean delivery rates in obese women may explain why we did not find 
association between instrumental delivery and obesity. But in a large study from London 
(Sebire NJ, et al 200187), no increased risk of instrumental delivery was seen, among 
obese  women.  Complete  perineal  tear  and shoulder  dystocia  was  not  seen  in  either 
groups, which may be due to the increased cesarean delivery rates and low instrumental 
delivery rates. 
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In accordance with other studies, (Myles et al 200269, Wolf HM et al 1998102) we 
found obese women to be at a greater risk of post-operative wound 
infection and wound dehiscence. Obese women had 2.47 fold and 3.12 fold increased 
risk for wound infection and dehiscence respectively.  Atonic hemorrhage occurred in 
one woman in each group, and the association was not statistically significant (Jensen et 
al 200351, Bainco et al 199811). This may be due to the active management of third stage 
of labour and reduced instrumental deliveries.
There are conflicting data in the literature regarding maternal obesity and preterm 
birth, with some studies (Baeten et al 20019) showing increased risk and some studies 
showing no change (Sebire et al 200187). In our study, no difference was found between 
either groups for preterm birth <37wks. The reason for the difference in study results 
may reflect difference in study population.
In our study, the mean birth weight of the neonates of obese group was 3.16kg 
and the neonates of control group was 2.92kg. As previously reported, (Ehrenberg et al 
200226,  Sibire et  al  200187) obese women had increased risk of delivering high birth 
weight babies. We found that 25% of obese group delivered babies 3.5kg and above, 
when compared to 8.87% of control group.
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Neonates of obese mothers had increased NICU admission, the major reasons for 
admission being infants of diabetic mothers and macrosomia. There was no difference in 
Apgar score at 5 min between the two groups. This is consistent with study done by Line 
Rode et al62.
As documented in previous studies, (Hood et al 199347 ) the obese women had 
prolonged hospital stay, which may be due to associated medical complications, wound 
infection and NICU admission.
SUMMARY
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SUMMARY
In our study, 99 obese women (BMI>30kg/m2 ) and 201 women with normal BMI 
(18.5kg/m2 _ 24.99kg/m2) were studied. It was observed that:
1. Obese women were slightly older than control group. Majority of obese women 
belonged to age group 25-29yrs when compared to control group ,who belonged 
to 20-24years age group.
2. The mean age of obese women was 27.01yrs and that of control women was 
24.14yrs.
3. The proportion of nulliparous women was less in obese group (36.36%) when 
compared to control group (45.77).  
4.    In obese group, the mean BMI increased with increase in parity.
5. Among obese group, majority (82.82%) was moderately obese, 12.12% were 
severely obese and 5.56% were very severely obese.
6. 18.18% of obese women had menstrual abnormalities when compared to 2.49% of 
control women.
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7. Infertility was seen in 20.2% of obese group and 2.49% in control group
8. Obese  women  had  increased  incidence  of  pre-existing  medical  disorders  like 
hypothyroidism,  when compared to control group. But no difference was seen 
with  respect  to  diabetes,  hypertension  and  other  morbidities  between  the  two 
groups.
9. Obese women had increased incidence of gestational diabetes when compared to 
control group (10.10% Vs 1.99%) . Obese group had 5.53 fold increased risk of 
gestational diabetes.
10. The incidence of pre -eclampsia was higher in obese group when compared to 
control group (13.13% Vs 5.97%). Obese women had 2.3 fold increased risk of 
developing pre-eclampsia.
11. Gestational hypertension was found to be higher in obese group when compared 
to control group (10.10% Vs 2.99%). The risk of gestational hypertension among 
obese group was increased almost 3.6 fold.
12. Obese women were more likely to be induced (12.1%, Odd’s Ratio: 2.55) when 
compared to control group (4.9%).
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13. Increased cesarean delivery rates was found among obese women (56.57%, Odd’s 
Ratio 2.8) when compared to control group (30.35%). The risk increased with 
increase in severity of obesity.
14. Nulliparous women had 2.5 fold increased risk of cesarean delivery when 
compared to women with normal BMI. 
15. Emergency primary cesarean deliveries were higher among obese group 
(31.34%,  Odd’s Ratio: 2.13,) when compared to control group (17.64%). 
Similarly elective primary cesarean delivery was also fond to be higher in obese 
group (5.97%, Odd’s Ratio: 2.09) when compared to control group(2,94%)
16. No difference was seen among obese and control group with respect to placenta 
previa,  abruptio  placenta,  malpresentation,  multiple  pregnancy,  instrumental 
deliveries, shoulder dystocia, complete perineal tears and hemorrhage.
17. Post  operative  wound  infections  and  wound  dehiscence  were  found  to  be 
increased  in  obese  group  (23.2%,  8.93%)  when  compared  to   control  group 
(9.84%, 1.67%) respectively(Odd’s Ratio: 2.47 and 3.12 respectively).
18. No difference was found in preterm births (<37 weeks) between two groups
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19. The majority of the neonates of obese women (44%) were between 3kg-3.49kg 
where as majority of neonates in control group (48.28%) were between 2.5kg – 
2.99kg.
20. Three babies of obese women were >4kg but none were in control group.
21. No difference was seen among obese and control group with respect to Apgar 
score at 5 Minutes. (3% Vs 0.49%) respectively. 
22. There were increased admissions to NICU among neonates of obese women 
(21%) when compared to control group (8.37%). The major reasons for 
admissions were for the care of infant of diabetic mother and macrosomia.
23. There was one still birth and one early neonatal death in obese group due to 
prematurity. None were there in control group
Prolonged hospital stay was required in obese group (26.26%) when compared to 
control group (10.95%). The major reasons for the prolonged stay were due to wound 
infections, medical disorders and NICU admissions.
CONCLUSION
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CONCLUSION
Our study points out the numerous maternal and perinatal risks in obese pregnant 
women which pose a considerable challenge to the obstetrical practitioner. In addition, 
massive obesity among women of  child bearing age is associated with a number of 
health  risks  later  in  life.  This  stresses  the  importance  of  concentrating  on  trying  to 
reduce  the  increasing   incidence  of  obesity  in  fertile  women.  The  best  time  of 
intervention  may  be  before  a  women  considers  a  pregnancy,  because  it  is  not 
recommended that obese women lose weight during pregnancy. 
This  implicates  the  need  of  pre-pregnancy  advice  and  counseling  to  young 
women.  Obese  women  considering  pregnancy  should  be  informed  of  the  risk  that 
maternal obesity confers on a pregnancy.
Health care professionals need to encourage and assist obese women to make life 
style changes, to lose weight pre-conceptually in an attempt to optimize and potentially 
decrease the risk of complication in pregnancy.  
Pregnancies among obese women must be classified as high risk pregnancies and 
appropriate antenatal care should be provided with heightened surveillance, anticipation 
and diagnosis of the complications and intervene earlier if complications arise.
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PROFORMA
PROFORMA
Serial No: Date of Admission:
Name: Age:
Husbands Name:
Address:
Occupation:
Socioeconomic Status:
Booking:
Immunisation:
History of present illness:
Menstrual history: Regular / Irregular
LMP:
EDD:
Marital History: Married Since:
Consangunity:
H/o Infertility:
Obesity History: G P L A
Last Child Birth
Previous Obstetric History: Details of Outcome
Personal History: Smoking -
Alcohol -
Diet -
Past Medical History: Diabetes :
Chronic Hypertension :
Heart Disease :
Others :
Drug Intake :
Childhood Obesity :
Past Surgical History:
Present Pregnancy:
I Trimester:
Hyperemisis
Fever
Radiation Exposure
Medications
Pain Abdomen
II Trimester:
Date of quickening
Bleeding PV
GDM
Pre-eclampsia
III Trimester:
Bleeding PV
GDM
Pre eclampsia
GENERAL EXAMINATION
Height at Booking:
Weight at Booking:
BMI at Booking:
Weight at delivery:
Anemia:
Edema:
Pulse: Respiration:
Blood Pressure:
Cardiovascular System:
Respiratory System:
Thyroid:
Breast:
Spine:
Gait:
OBSTETRIC EXAMINATION
Per abdomen
Fundal height
Abdominal girth:
Fundal grip:
Umbilical grip:
I pelvic grip:
II Pelvic grip:
Fetal heart:
Liquor volume:
Estimated fetal weight:
PELVIC EXAMINATION:
Investigations:
Urine: Albumin
Sugar
Culture/Sensitivity
Blood: Hemoglobin:
PCV:
Blood Sugar:
Urea: Others:
S. Creatinine:
Ultra Sound:
ANTEPARTUM COMPLICATION:
Gestational Diabetes:
Pre-eclampsia :
Gestational Hypertension:
Placenta Previa:
Abruptio Placenta:
Malpresentation:
DELIVERY DETAILS:
Induction of Labor: Yes/No
Indication for Induction:
Date of Delivery:
MODE OF DELIVERY:
Labor Natural: VBAC:
Forceps Delivery:
Cesarean delivery: Elective /Emergency
Indication for Cesarean delivery:
INTRAPARTUM COMPLICATIONS:
Shoulder dystocia :
Postpartum hemorrhage:
Complete perineal tear:
Colour of the liquour:
POSTPARTUM COMPLICATIONS:
Wound Infections:
Wound dehiscence:
Deep vein Thrombosis:
Fever:
NEONATE
Live Born: Still Born: Intrauterine death
Apgar: 1 Min 5 Min
Gestational age at delivery:
Birth weight:
Sex of the baby: M F
Congenital Abnormalities:
Admission in NICU:
Reason for admission in NICU:
Neonatal death:
Condition at Discharge:
Date of Discharge:
Duration of Hospital Stay: 
Vaginal Delivery: 2 days >2 days
Cesarean Delivery: 7 days >7 days
